The A-share chemical pharmaceutical sector fluctuated and weakened, with Shenqi Pharmaceutical hitting the daily limit down, and other companies such as Progen Pharmaceuticals, Minova, Shapuaisi, Yuhang Pharmaceutical, Harbin Pharmaceutical Group, and Lemei Pharmaceutical following suit.